Double-blind Placebo Controlled Study of Oxytocin in Fragile X Syndrome

NCT01254045 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Fragile X Syndrome

Interventions

DRUG: placebo
DRUG: oxytocin 24IU
DRUG: oxytocin 48IU

Sponsor

Stanford University